Exposure of BRAF‐mutant melanoma cells to MAPK inhibitors initially induces up‐regulation of JNK/c‐Jun signaling, a known regulator of EMT‐related genes and of cell adhesion and ECM molecules (Liu et al, 2015; Ramsdale et al, 2015). The gene discussed is JUN; the disease is melanoma.